Filing Flows › Medinotec (MDNC) › Q2 FY27
Medinotec (MDNC) Q2 FY27 earnings results (second quarter fiscal 2027)
10-Q filed Oct 8, 2026
Medinotec (MDNC) reported revenue of $3.2M for the second quarter fiscal 2027 (Q2 FY27), -1% from a year earlier and +21% from the quarter before. Operating margin was 6.3%, net earnings $41K (1.3% of revenue).
Medinotec, Q2 FY27: revenue $3.2M (-1% year over year), operating margin 6.3%, net earnings $41K, operating cash flow $108K. The chart follows the revenue to costs, profit and cash.
| Q2 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | +21% | -1% |
| Gross profit | $1.6M | +19% | -21% |
| Operating profit | $203K | +12% | -62% |
| Net earnings | $41K | -82% | -88% |
| Operating cash flow | $108K | — | -91% |
| Free cash flow | $61K | — | — |
What changed
Revenue was $3.2M in Q2 FY27, down 1% year over year and up 21% from the previous quarter. Outside U S A Distribution Agreement Sales was the largest line at 86% of revenue. Outside U S A Internally Designed Manufactured Sales lost $66K year over year (down 21%), 185% of the total change.
Gross margin was 48.7%, down 12.5 points from Q2 FY26. Operating profit was $203K, a 6.3% margin (down 10.0 points year over year). Operating expenses fell 7% while revenue fell 1%. The fastest-growing cost line was Other operating costs (+191%). Net earnings were $41K, down 88% year over year. The effective tax rate was 77.3%.
Operating cash flow was $108K (down 91% year over year), 263% of net earnings. Non-cash charges added back $22K of depreciation and amortization. Working capital and other items added $45K. Capital expenditures of $47K left free cash flow of $61K.
Questions
What was Medinotec's revenue in the second quarter fiscal 2027?
Medinotec (MDNC) reported revenue of $3.2M for the second quarter fiscal 2027 (Q2 FY27), -1% from a year earlier and +21% from the quarter before.
Was Medinotec profitable in the second quarter fiscal 2027?
Operating profit was $203K (6.3% of revenue) and net earnings $41K.
Source: Medinotec 10-Q on SEC EDGAR.